Developer docs
API playgroundTry for free, no card

Search company profiles

BioAssay Systems

Full company profile

uuid000jwab

Namestring
BioAssay Systems
Legal namestring
BioAssay Systems
Websiteurl
bioassaysys.com
Company typeenum
Private
Founded yearint
2003
Descriptiontext

BioAssay Systems is a privately held life sciences tools company founded in 2003 and headquartered in Hayward, California (San Francisco Bay Area), operating under a Vion Biosciences affiliation. The company develops and manufactures a catalog of more than 280 assay kits spanning enzyme activity, metabolism, oxidative stress, signal transduction, oncology, and cations/anions applications, organized under the EnzyChrom (colorimetric), QuantiChrom (quantitative colorimetric), QuantiFluo (fluorimetric), and EnzyFluo (fluorescent immunoassay) brand families. Detection technologies rely on absorbance, fluorescence (including FI, FP, TRF, and FRET), and luminescence readouts optimized for 96/384-well high-throughput plate formats, with proprietary methods including a patented turbidometric Protein Disulfide Isomerase inhibitor screening assay (US Patent 6,977,142) and a kinetic fluorometric PLA/PLGA polymer quantification assay developed for medical device degradation testing.

The company monetizes through two revenue streams: one-time product sales of catalog kits (priced individually between approximately $199 and $679) and fee-for-service offerings covering analytical sample testing, custom assay development, and lead discovery support including ADMET profiling, kinase inhibitor screening, and cell-based assays. Distribution is multi-channel, combining direct e-commerce through bioassaysys.com, major laboratory supply distributors Fisher Scientific and VWR, and marketplace platforms ScienceExchange and Scientist.com, with cold-chain shipping into more than 60 countries.

BioAssay Systems serves a horizontally diversified customer base that includes academic researchers (Santa Clara University), mid-market pharmaceutical companies (Orinda Pharma), medical device manufacturers (XTENT, Inc. for drug-eluting stent polymer quantification), and startups (DermaTec LLC). Value propositions center on validated ready-to-use kits, custom assay design, fast service turnaround (results often within 24-48 hours), and vertically integrated manufacturing that enables competitive pricing. The company operates with 11-50 employees and has not disclosed external funding rounds, suggesting a self-sustaining niche player rather than a venture-backed high-growth profile.

Short descriptiontext

BioAssay Systems develops and manufactures 280+ assay kits and provides custom assay and lead discovery services for life sciences research, drug discovery, and medical device testing, serving academic, pharmaceutical, and medical device customers across 60+ countries via direct, distributor, and marketplace channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHayward, United States
HQ citystring
Hayward
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
assay kits, drug discovery reagents, enzyme activity assays, signal transduction assays, high-throughput screening
Industry1 code
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Scientific Research and Development Services5417
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
Product category
Life Sciences Assay Kits
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Assay Products and Kits
TypeOne Time License
Description

Sale of proprietary assay kits and reagents for life sciences research and drug discovery. Products include enzyme activity kits, metabolism assays, oxidative stress markers, signal transduction assays, and more across 280+ product catalog.

bioassaysys.com
2Lead Discovery Services
TypeProfessional Services
Description

Fee-for-service drug discovery support including enzyme inhibitor screening, signal transduction profiling, ADMET testing, and mitochondrial membrane potential assays.

bioassaysys.com
3Assay Customization Services
TypeProfessional Services
Description

Custom assay development and optimization services modifying existing kits or creating novel assays for specific customer requirements.

bioassaysys.com
4Analytical Services
TypeProfessional Services
Description

Sample analysis services performing biological sample testing including oxidative stress markers, metabolic markers, oncological markers, and cell-based assays.

bioassaysys.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Standard assay kits sold individually with tiered pricing based on quantity
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products available at various price points; bulk discounts implied through quantity-based pricing visible on website. Sample prices: $199-$679 per 100-test kit.

bioassaysys.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

BioAssay Systems develops, manufactures, and sells a catalog of 280+ proprietary assay kits and reagents for life sciences research and drug discovery, covering enzyme activity, signal transduction (phosphorylation ELISA), metabolism, oxidative stress, oncology, diabetes/obesity, and cation/anion targets using absorbance, fluorescence, and luminescence detection chemistries. The company also offers fee-for-service laboratory services including analytical testing, assay customization, novel assay design and development, and high-throughput lead discovery (enzyme inhibitor screening, ADMET profiling, cell viability, mitochondrial membrane potential, and solubility assays).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Assay results delivered within 24-48 hours for standard services
+1 more record
Product overview1 text field

BioAssay Systems develops and manufactures a comprehensive portfolio of assay kits and provides laboratory services for life sciences research and drug discovery. The product portfolio includes multiple assay kit brands: EnzyChrom™ kits for colorimetric assays, QuantiChrom™ kits for quantitative colorimetric assays, QuantiFluo™ kits for fluorimetric assays, and EnzyFluo™ kits for high-sensitivity fluorescent immunoassays. Key product categories include enzyme activity assays, phosphorylation ELISA kits for signal transduction pathways (AKT1, AMPK, ERK, NFκB, GSK3, 4EBP1, LKB1, RPS6, SHP2), metabolism assays (lactate, creatine, citrate, choline), and diabetes/obesity research assays. The company also provides fee-for-service offerings including analytical services, assay customization, assay design and development, and lead discovery services (enzyme inhibitor screening, ADMET profiling, cell-based assays). Founded in 2003 in the San Francisco Bay Area, the company has developed over 250 assay kits with products distributed in over 60 countries.

Product and service27 records
1EnzyChrom™ Enzyme Activity Assay Kits
CategoryEnzyme Activity Assay Kits
Description

Colorimetric enzymatic assay kits covering kinases, phosphatases, dehydrogenases, oxidoreductases, and metabolic enzymes (catalase, creatine kinase, α-amylase, aldehyde dehydrogenase, glutathione peroxidase/reductase, glucose oxidase, fumarase, invertase, aspartate transaminase, aconitase, and others) for life sciences and drug discovery research.

2EnzyFluo™ Phosphorylation ELISA Kits (Signal Transduction)
CategorySignal Transduction Assay Kits
Description

Quantitative fluorescent immunoenzymatic assays measuring phosphorylation status of key signaling proteins—NFkB (p65 Ser-536), AMPK (Thr-172), ERK1/2 (T202/Y204, T185/Y187), AKT1 (S473), 4EBP1 (S65), RPS6 (S235/236), SHP2 (Y542), LKB1 (S431), GSK3A (S21), GSK3B (S9)—in cultured whole cells without cell lysis, normalizing phosphorylation to total protein. Includes a customizable cell-based ELISA format for user-specified targets.

3EnzyChrom™ Metabolism Assay Kits
CategoryMetabolism Assay Kits
Description

Colorimetric and fluorimetric assays for quantifying metabolic markers in biological samples, including D-lactate, L-lactate, creatine, citrate, choline, D-mannitol, cholesterol, free fatty acids, fumarate, ascorbic acid, coenzyme A, glucose, and uric acid for metabolic, food, beverage, and agricultural research.

4QuantiChrom™ and QuantiFluo™ Oxidative Stress Assay Kits
CategoryOxidative Stress Assay Kits
Description

Quantitative colorimetric and fluorimetric kits for measuring oxidative stress markers, including peroxide (peroxide assay kits I and II) and other reactive oxygen species indicators for oxidative stress research.

5EnzyFluo™ and QuantiFluo™ High-Throughput Screening Reagents & Kits
CategoryHigh-Throughput Screening Reagents
Description

Fluorescent and fluorimetric assay reagents optimized for high-throughput screening in 96/384-well plate formats for drug discovery applications. Includes QuantiFluo acid phosphatase, ammonia, and diamine oxidase kits alongside signal transduction and metabolism HTS formats.

6Inhibitor HTS Kits
CategoryInhibitor High-Throughput Screening Kits
Description

Assay kits developed for inhibitor screening applications in high-throughput drug discovery workflows targeting kinases, phosphatases, and signaling proteins, used alongside signal transduction kits.

7EnzyChrom™ Diabetes & Obesity Assay Kits
CategoryDiabetes and Obesity Assay Kits
Description

Colorimetric assay kits for adipogenesis and adipolysis quantification supporting diabetes and obesity research.

8Oncology Assay Kits
CategoryOncology Assay Kits
Description

Assay kits supporting oncology research, including metabolism, signaling, and biomarker targets aligned with the BioAssay Systems broader portfolio.

9Cations & Anions Assay Kits
CategoryCation and Anion Assay Kits
Description

Colorimetric assay kits for quantifying cations and anions in biological, food, beverage, and agricultural samples, including QuantiChrom zinc kits (I and II).

10Blood & Urine Chemistry Assay Kits
CategoryBlood and Urine Chemistry Assay Kits
Description

Colorimetric and fluorimetric kits for quantifying clinical chemistry markers in serum, plasma, and urine, including creatine kinase, alanine transaminase, aspartate transaminase, glucose, uric acid, and other analytes for clinical and preclinical research.

11Food & Beverage Analysis Assay Kits
CategoryFood and Beverage Analysis Kits
Description

Colorimetric and fluorimetric kits for quantifying analytes in food, beverage, and agricultural samples, including choline, citrate, D-mannitol, and related metabolites for quality control and analysis.

12Agriculture & Environment Assay Kits
CategoryAgriculture and Environment Assay Kits
Description

Colorimetric and fluorimetric kits for quantifying analytes in agricultural and environmental samples, including D-mannitol and QuantiFluo ammonia for water and soil analysis applications.

13Quick Test Strips
CategoryQuick Test Strips
Description

Rapid test strips for point-of-use measurement of analytes, complementing the company's colorimetric and fluorimetric assay kits.

14Polylactate (PLA/PLGA) Assay Service
CategoryCustom Assay Service
Description

Proprietary kinetic fluorometric assay service that quantifies D-lactate-containing polymers (PLA and PLGA) in tissue samples for medical device degradation assessment used in CE Mark and FDA IDE regulatory submissions.

15Analytical Services
CategoryAnalytical Laboratory Service
Description

Bioanalysis of biological samples including oxidative stress markers, metabolic markers, oncological markers, signal transduction measurements, and cation/anion analysis performed by BioAssay Systems laboratory staff, with results typically delivered within 24 to 48 hours.

16Assay Customization Service
CategoryAssay Customization Service
Description

Customization and optimization of existing BioAssay Systems assay kits to fit specific customer requirements, modifying protocols for unique experimental setups.

17Assay Design & Development Service
CategoryNovel Assay Development Service
Description

Novel assay development from concept through sample testing, including format development for 96/384-well plates, cuvette-based, and paper-based assay formats tailored to specific customer research needs.

18Lead Discovery Services
CategoryLead Discovery Service
Description

High-throughput drug discovery screening services including enzyme inhibitor screening, signal transduction profiling, ADMET analysis, and mitochondrial membrane potential assays for pharmaceutical and biotechnology customers running hit-to-lead and lead optimization programs.

19Kinase Inhibitor Screening Service
CategoryLead Discovery Service
Description

High-throughput kinase inhibitor screening service with IC50 determination, evaluating test compounds as inhibitors of kinase activity for drug discovery programs.

20NFκB Phosphorylation Status Screening Service
CategoryLead Discovery Service
Description

Screening service for modulators affecting NFκB phosphorylation with kinetics, EC50, and IC50 determination.

21AMPK Phosphorylation Status Screening Service
CategoryLead Discovery Service
Description

Screening service for modulators affecting AMPK phosphorylation with kinetics, EC50, and IC50 determination.

22ERK Phosphorylation Status Screening Service
CategoryLead Discovery Service
Description

Screening service for modulators affecting ERK phosphorylation with kinetics, EC50, and IC50 determination.

23ADMET Services
CategoryADMET Profiling Service
Description

Absorption, Distribution, Metabolism, Excretion, and Toxicity screening services including solubility (filter plate and shake flask methods), membrane permeability (BBB, GI, skin via PAMPA), and in vitro cell viability testing for preclinical drug discovery customers.

24Membrane Permeability Services
CategoryADMET Profiling Service
Description

PAMPA-based permeability testing for blood brain barrier (BBB), gastrointestinal (GI), and skin permeability assessment in drug discovery workflows.

25In Vitro Cell Viability Service
CategoryADMET Profiling Service
Description

Cell viability testing service using ATP levels, LDH release, and cellular reduction capacity methods for compound toxicity and efficacy profiling.

26Mitochondrial Membrane Potential Service
CategoryLead Discovery Service
Description

High-throughput screening service measuring mitochondrial membrane potential in living mammalian cells and permeabilized yeast for drug discovery and toxicity profiling.

27Solubility Services (Filter Plate & Shake Flask)
CategoryADMET Profiling Service
Description

Quantitative solubility testing using filter plate method (1.5-hour turnaround) and shake flask method (18-hour turnaround) for compound characterization in drug discovery.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major laboratory supply distributor offering BioAssay Systems assay products through their extensive catalog of life sciences research products.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Laboratory supply distributor providing global distribution of BioAssay Systems products alongside other research reagent suppliers.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Online laboratory services marketplace listing BioAssay Systems products and services for researcher discovery and ordering.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Scientific marketplace platform where BioAssay Systems maintains a provider profile and offers products and assay services.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Ann Arbor-based manufacturer of biochemical assay kits, reagents, and research tools for life sciences. Directly comparable to BioAssay Systems in catalog breadth (enzyme activity, metabolism, oxidative stress assays) and customer base (academic and pharma researchers).

TypeDirect peer
Description

Specializes in antibodies and ELISA/assay kits targeting signaling pathways (AKT, MAPK, NFkB, AMPK). Overlaps directly with BioAssay Systems' EnzyFluo™ phosphorylation product line and shares the same biopharma/academic customer profile.

TypeDirect peer
Description

Develops and sells assay kits, labeling reagents, and small molecules for life sciences research. Comparable catalog breadth (oxidative stress, apoptosis, metabolism assays) and similar distribution model via direct sales and major lab supply distributors.

TypeBroad incumbent
Description

Global life sciences tools company offering a vast catalog of antibodies, ELISA kits, and assay kits. Much larger than BioAssay Systems but competes head-to-head in research-use immunoassay and cell-based assay categories, including after its acquisition of BioVision.

TypeBroad incumbent
Description

Major life sciences tools provider with broad portfolio including cell-based assays, kinase assays, and ADMET/toxicology services. Comparable on both kit products and services, though at significantly larger scale and broader geographic reach.

TypeBroad incumbent
Description

Diversified life sciences and clinical diagnostics manufacturer with a significant assay kits and reagents business. Competes with BioAssay Systems across multiple assay categories but operates at vastly greater scale with dedicated enterprise sales.

TypeDirect peer
Description

Mid-sized developer of immunoassay and enzymatic assay kits for research use, focused on hormone, oxidative stress, and environmental testing. Closely comparable in scale, product philosophy (easy-to-use kits), and target customer mix.

TypeDirect peer
Description

Specializes in fluorescent and luminescent assay kits, reagents, and instruments for life sciences and drug discovery. Overlaps with BioAssay Systems' EnzyFluo™ and QuantiFluo™ fluorimetric product lines and shares HTS drug discovery customer use cases.

TypeDirect peer
Description

Provides peptides, antibodies, and assay kits (including protease, kinase, and cell signaling assays). Now part of Kaneka Corporation, it competes directly in the same research-use assay market that BioAssay Systems serves.

10MilliporeSigma (Sigma-Aldrich)
TypeBroad incumbent
Description

Largest life sciences reagents and kits supplier globally; offers extensive assay kits (enzymatic, ELISA, fluorescent) overlapping many of BioAssay Systems' catalog items. Sets the pricing and distribution benchmark for the entire niche.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioAssay Systems

Life Sciences Assay Kitsbioassaysys.com

BioAssay Systems develops and manufactures 280+ assay kits and provides custom assay and lead discovery services for life sciences research, drug discovery, and medical device testing, serving academic, pharmaceutical, and medical device customers across 60+ countries via direct, distributor, and marketplace channels.

What BioAssay Systems does

BioAssay Systems is a privately held life sciences tools company founded in 2003 and headquartered in Hayward, California (San Francisco Bay Area), operating under a Vion Biosciences affiliation. The company develops and manufactures a catalog of more than 280 assay kits spanning enzyme activity, metabolism, oxidative stress, signal transduction, oncology, and cations/anions applications, organized under the EnzyChrom (colorimetric), QuantiChrom (quantitative colorimetric), QuantiFluo (fluorimetric), and EnzyFluo (fluorescent immunoassay) brand families. Detection technologies rely on absorbance, fluorescence (including FI, FP, TRF, and FRET), and luminescence readouts optimized for 96/384-well high-throughput plate formats, with proprietary methods including a patented turbidometric Protein Disulfide Isomerase inhibitor screening assay (US Patent 6,977,142) and a kinetic fluorometric PLA/PLGA polymer quantification assay developed for medical device degradation testing.

The company monetizes through two revenue streams: one-time product sales of catalog kits (priced individually between approximately $199 and $679) and fee-for-service offerings covering analytical sample testing, custom assay development, and lead discovery support including ADMET profiling, kinase inhibitor screening, and cell-based assays. Distribution is multi-channel, combining direct e-commerce through bioassaysys.com, major laboratory supply distributors Fisher Scientific and VWR, and marketplace platforms ScienceExchange and Scientist.com, with cold-chain shipping into more than 60 countries.

BioAssay Systems serves a horizontally diversified customer base that includes academic researchers (Santa Clara University), mid-market pharmaceutical companies (Orinda Pharma), medical device manufacturers (XTENT, Inc. for drug-eluting stent polymer quantification), and startups (DermaTec LLC). Value propositions center on validated ready-to-use kits, custom assay design, fast service turnaround (results often within 24-48 hours), and vertically integrated manufacturing that enables competitive pricing. The company operates with 11-50 employees and has not disclosed external funding rounds, suggesting a self-sustaining niche player rather than a venture-backed high-growth profile.

BioAssay Systems firmographics

Firmographics
Name
BioAssay Systems
Legal name
BioAssay Systems
Website
https://bioassaysys.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
11–50 employees
Short description
BioAssay Systems develops and manufactures 280+ assay kits and provides custom assay and lead discovery services for life sciences research, drug discovery, and medical device testing, serving academic, pharmaceutical, and medical device customers across 60+ countries via direct, distributor, and marketplace channels.
Ownership category
akta.pro rank

BioAssay Systems industry classification

Industry
Product category
Life Sciences Assay Kits
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Scientific Research and Development Services (5417)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)

Keywords

  • Assay kits
  • Drug discovery reagents
  • Enzyme activity assays
  • Signal transduction assays
  • High-throughput screening

Where BioAssay Systems is headquartered

Location

Headquarters

HQ city
Hayward
HQ country
United States
HQ region
North America

Offices2 records

Markets served

BioAssay Systems business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Assay Products and Kits: Sale of proprietary assay kits and reagents for life sciences research and drug discovery. Products include enzyme activity kits, metabolism assays, oxidative stress markers, signal transduction assays, and more across 280+ product catalog.
  2. Lead Discovery Services: Fee-for-service drug discovery support including enzyme inhibitor screening, signal transduction profiling, ADMET testing, and mitochondrial membrane potential assays.
  3. Assay Customization Services: Custom assay development and optimization services modifying existing kits or creating novel assays for specific customer requirements.
  4. Analytical Services: Sample analysis services performing biological sample testing including oxidative stress markers, metabolic markers, oncological markers, and cell-based assays.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard assay kits sold individually with tiered pricing based on quantity

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

BioAssay Systems product offering

Product offering

Core offering

BioAssay Systems develops, manufactures, and sells a catalog of 280+ proprietary assay kits and reagents for life sciences research and drug discovery, covering enzyme activity, signal transduction (phosphorylation ELISA), metabolism, oxidative stress, oncology, diabetes/obesity, and cation/anion targets using absorbance, fluorescence, and luminescence detection chemistries. The company also offers fee-for-service laboratory services including analytical testing, assay customization, novel assay design and development, and high-throughput lead discovery (enzyme inhibitor screening, ADMET profiling, cell viability, mitochondrial membrane potential, and solubility assays).

Product overview

BioAssay Systems develops and manufactures a comprehensive portfolio of assay kits and provides laboratory services for life sciences research and drug discovery. The product portfolio includes multiple assay kit brands: EnzyChrom™ kits for colorimetric assays, QuantiChrom™ kits for quantitative colorimetric assays, QuantiFluo™ kits for fluorimetric assays, and EnzyFluo™ kits for high-sensitivity fluorescent immunoassays. Key product categories include enzyme activity assays, phosphorylation ELISA kits for signal transduction pathways (AKT1, AMPK, ERK, NFκB, GSK3, 4EBP1, LKB1, RPS6, SHP2), metabolism assays (lactate, creatine, citrate, choline), and diabetes/obesity research assays. The company also provides fee-for-service offerings including analytical services, assay customization, assay design and development, and lead discovery services (enzyme inhibitor screening, ADMET profiling, cell-based assays). Founded in 2003 in the San Francisco Bay Area, the company has developed over 250 assay kits with products distributed in over 60 countries.

Differentiator

Problem solved

Functional benefit

Products and services

  • EnzyChrom™ Enzyme Activity Assay Kits Colorimetric enzymatic assay kits covering kinases, phosphatases, dehydrogenases, oxidoreductases, and metabolic enzymes (catalase, creatine kinase, α-amylase, aldehyde dehydrogenase, glutathione peroxidase/reductase, glucose oxidase, fumarase, invertase, aspartate transaminase, aconitase, and others) for life sciences and drug discovery research.
  • EnzyFluo™ Phosphorylation ELISA Kits (Signal Transduction) Quantitative fluorescent immunoenzymatic assays measuring phosphorylation status of key signaling proteins—NFkB (p65 Ser-536), AMPK (Thr-172), ERK1/2 (T202/Y204, T185/Y187), AKT1 (S473), 4EBP1 (S65), RPS6 (S235/236), SHP2 (Y542), LKB1 (S431), GSK3A (S21), GSK3B (S9)—in cultured whole cells without cell lysis, normalizing phosphorylation to total protein. Includes a customizable cell-based ELISA format for user-specified targets.
  • EnzyChrom™ Metabolism Assay Kits Colorimetric and fluorimetric assays for quantifying metabolic markers in biological samples, including D-lactate, L-lactate, creatine, citrate, choline, D-mannitol, cholesterol, free fatty acids, fumarate, ascorbic acid, coenzyme A, glucose, and uric acid for metabolic, food, beverage, and agricultural research.
  • QuantiChrom™ and QuantiFluo™ Oxidative Stress Assay Kits Quantitative colorimetric and fluorimetric kits for measuring oxidative stress markers, including peroxide (peroxide assay kits I and II) and other reactive oxygen species indicators for oxidative stress research.
  • EnzyFluo™ and QuantiFluo™ High-Throughput Screening Reagents & Kits Fluorescent and fluorimetric assay reagents optimized for high-throughput screening in 96/384-well plate formats for drug discovery applications. Includes QuantiFluo acid phosphatase, ammonia, and diamine oxidase kits alongside signal transduction and metabolism HTS formats.
  • Inhibitor HTS Kits Assay kits developed for inhibitor screening applications in high-throughput drug discovery workflows targeting kinases, phosphatases, and signaling proteins, used alongside signal transduction kits.
  • EnzyChrom™ Diabetes & Obesity Assay Kits Colorimetric assay kits for adipogenesis and adipolysis quantification supporting diabetes and obesity research.
  • Oncology Assay Kits Assay kits supporting oncology research, including metabolism, signaling, and biomarker targets aligned with the BioAssay Systems broader portfolio.
  • Cations & Anions Assay Kits Colorimetric assay kits for quantifying cations and anions in biological, food, beverage, and agricultural samples, including QuantiChrom zinc kits (I and II).
  • Blood & Urine Chemistry Assay Kits Colorimetric and fluorimetric kits for quantifying clinical chemistry markers in serum, plasma, and urine, including creatine kinase, alanine transaminase, aspartate transaminase, glucose, uric acid, and other analytes for clinical and preclinical research.
  • Food & Beverage Analysis Assay Kits Colorimetric and fluorimetric kits for quantifying analytes in food, beverage, and agricultural samples, including choline, citrate, D-mannitol, and related metabolites for quality control and analysis.
  • Agriculture & Environment Assay Kits Colorimetric and fluorimetric kits for quantifying analytes in agricultural and environmental samples, including D-mannitol and QuantiFluo ammonia for water and soil analysis applications.
  • Quick Test Strips Rapid test strips for point-of-use measurement of analytes, complementing the company's colorimetric and fluorimetric assay kits.
  • Polylactate (PLA/PLGA) Assay Service Proprietary kinetic fluorometric assay service that quantifies D-lactate-containing polymers (PLA and PLGA) in tissue samples for medical device degradation assessment used in CE Mark and FDA IDE regulatory submissions.
  • Analytical Services Bioanalysis of biological samples including oxidative stress markers, metabolic markers, oncological markers, signal transduction measurements, and cation/anion analysis performed by BioAssay Systems laboratory staff, with results typically delivered within 24 to 48 hours.
  • Assay Customization Service Customization and optimization of existing BioAssay Systems assay kits to fit specific customer requirements, modifying protocols for unique experimental setups.
  • Assay Design & Development Service Novel assay development from concept through sample testing, including format development for 96/384-well plates, cuvette-based, and paper-based assay formats tailored to specific customer research needs.
  • Lead Discovery Services High-throughput drug discovery screening services including enzyme inhibitor screening, signal transduction profiling, ADMET analysis, and mitochondrial membrane potential assays for pharmaceutical and biotechnology customers running hit-to-lead and lead optimization programs.
  • Kinase Inhibitor Screening Service High-throughput kinase inhibitor screening service with IC50 determination, evaluating test compounds as inhibitors of kinase activity for drug discovery programs.
  • NFκB Phosphorylation Status Screening Service Screening service for modulators affecting NFκB phosphorylation with kinetics, EC50, and IC50 determination.
  • AMPK Phosphorylation Status Screening Service Screening service for modulators affecting AMPK phosphorylation with kinetics, EC50, and IC50 determination.
  • ERK Phosphorylation Status Screening Service Screening service for modulators affecting ERK phosphorylation with kinetics, EC50, and IC50 determination.
  • ADMET Services Absorption, Distribution, Metabolism, Excretion, and Toxicity screening services including solubility (filter plate and shake flask methods), membrane permeability (BBB, GI, skin via PAMPA), and in vitro cell viability testing for preclinical drug discovery customers.
  • Membrane Permeability Services PAMPA-based permeability testing for blood brain barrier (BBB), gastrointestinal (GI), and skin permeability assessment in drug discovery workflows.
  • In Vitro Cell Viability Service Cell viability testing service using ATP levels, LDH release, and cellular reduction capacity methods for compound toxicity and efficacy profiling.
  • Mitochondrial Membrane Potential Service High-throughput screening service measuring mitochondrial membrane potential in living mammalian cells and permeabilized yeast for drug discovery and toxicity profiling.
  • Solubility Services (Filter Plate & Shake Flask) Quantitative solubility testing using filter plate method (1.5-hour turnaround) and shake flask method (18-hour turnaround) for compound characterization in drug discovery.

Quantifiable outcome

  • Assay results delivered within 24-48 hours for standard services
  • +1 more outcomes

Companies that use BioAssay Systems

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

BioAssay Systems technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

BioAssay Systems partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Fisher ScientificcoreChannel Partner/ Reseller/ DistributorMajor laboratory supply distributor offering BioAssay Systems assay products through their extensive catalog of life sciences research products.
  • VWRcoreChannel Partner/ Reseller/ DistributorLaboratory supply distributor providing global distribution of BioAssay Systems products alongside other research reagent suppliers.
  • ScienceExchangeminorChannel Partner/ Reseller/ DistributorOnline laboratory services marketplace listing BioAssay Systems products and services for researcher discovery and ordering.
  • Scientist.comminorChannel Partner/ Reseller/ DistributorScientific marketplace platform where BioAssay Systems maintains a provider profile and offers products and assay services.

Scale indicators4 records

Recent moves1 record

Expansion highlights5 records

BioAssay Systems competitors and assessment

Company assessment

Direct peers

  • Cayman Chemical: Ann Arbor-based manufacturer of biochemical assay kits, reagents, and research tools for life sciences. Directly comparable to BioAssay Systems in catalog breadth (enzyme activity, metabolism, oxidative stress assays) and customer base (academic and pharma researchers).
  • Cell Signaling Technology: Specializes in antibodies and ELISA/assay kits targeting signaling pathways (AKT, MAPK, NFkB, AMPK). Overlaps directly with BioAssay Systems' EnzyFluo™ phosphorylation product line and shares the same biopharma/academic customer profile.
  • Enzo Life Sciences: Develops and sells assay kits, labeling reagents, and small molecules for life sciences research. Comparable catalog breadth (oxidative stress, apoptosis, metabolism assays) and similar distribution model via direct sales and major lab supply distributors.
  • Arbor Assays: Mid-sized developer of immunoassay and enzymatic assay kits for research use, focused on hormone, oxidative stress, and environmental testing. Closely comparable in scale, product philosophy (easy-to-use kits), and target customer mix.
  • AAT Bioquest: Specializes in fluorescent and luminescent assay kits, reagents, and instruments for life sciences and drug discovery. Overlaps with BioAssay Systems' EnzyFluo™ and QuantiFluo™ fluorimetric product lines and shares HTS drug discovery customer use cases.
  • AnaSpec (Kaneka): Provides peptides, antibodies, and assay kits (including protease, kinase, and cell signaling assays). Now part of Kaneka Corporation, it competes directly in the same research-use assay market that BioAssay Systems serves.

Broad incumbents

  • Abcam: Global life sciences tools company offering a vast catalog of antibodies, ELISA kits, and assay kits. Much larger than BioAssay Systems but competes head-to-head in research-use immunoassay and cell-based assay categories, including after its acquisition of BioVision.
  • Promega Corporation: Major life sciences tools provider with broad portfolio including cell-based assays, kinase assays, and ADMET/toxicology services. Comparable on both kit products and services, though at significantly larger scale and broader geographic reach.
  • Bio-Rad Laboratories: Diversified life sciences and clinical diagnostics manufacturer with a significant assay kits and reagents business. Competes with BioAssay Systems across multiple assay categories but operates at vastly greater scale with dedicated enterprise sales.
  • MilliporeSigma (Sigma-Aldrich): Largest life sciences reagents and kits supplier globally; offers extensive assay kits (enzymatic, ELISA, fluorescent) overlapping many of BioAssay Systems' catalog items. Sets the pricing and distribution benchmark for the entire niche.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

BioAssay Systems social profiles

Digital presence

BioAssay Systems financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioAssay Systems leadership team

Management profile

Number of profiles

Profiles1 record

BioAssay Systems funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioAssay Systems M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioAssay Systems

What does BioAssay Systems do?

BioAssay Systems develops, manufactures, and sells a catalog of 280+ proprietary assay kits and reagents for life sciences research and drug discovery, covering enzyme activity, signal transduction (phosphorylation ELISA), metabolism, oxidative stress, oncology, diabetes/obesity, and cation/anion targets using absorbance, fluorescence, and luminescence detection chemistries. The company also offers fee-for-service laboratory services including analytical testing, assay customization, novel assay design and development, and high-throughput lead discovery (enzyme inhibitor screening, ADMET profiling, cell viability, mitochondrial membrane potential, and solubility assays).

Is BioAssay Systems a public or private company?

BioAssay Systems is a private company. It is classified as corporate owned and is currently operating.

When was BioAssay Systems founded?

BioAssay Systems was founded in 2003. It employs 11 to 50 people.

Where is BioAssay Systems based?

BioAssay Systems is headquartered in Hayward, United States, in the North America region.

How does BioAssay Systems make money?

Four revenue lines are on record. Assay Products and Kits are the primary driver. The others are lead Discovery Services, assay Customization Services and analytical Services.

Who are BioAssay Systems's main competitors?

Direct peers on record are Cayman Chemical, Cell Signaling Technology, Enzo Life Sciences, Arbor Assays, AAT Bioquest and AnaSpec (Kaneka). Broad incumbents are Abcam, Promega Corporation, Bio-Rad Laboratories and MilliporeSigma (Sigma-Aldrich).

Does BioAssay Systems have an API?

No public API is recorded for BioAssay Systems.

What industry is BioAssay Systems in?

BioAssay Systems's product category is Life Sciences Assay Kits. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals